Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01148277Phase 4Unknown
Phase 4, randomised, open-label trial of propofol (3 arms), sponsored by Ziv Medical Center. Primary endpoint: Safety and efficacy of propofol in liver diseases at 3 hours. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01148277.